Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 17 | 2023 | 329 | 7.090 |
Why?
|
| Mastectomy | 7 | 2023 | 17 | 1.780 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2019 | 18 | 1.340 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2019 | 178 | 1.130 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2022 | 2 | 0.900 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2022 | 13 | 0.890 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 15 | 0.860 |
Why?
|
| Mammaplasty | 1 | 2021 | 2 | 0.830 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 441 | 0.790 |
Why?
|
| Retrospective Studies | 10 | 2023 | 3273 | 0.750 |
Why?
|
| Female | 18 | 2023 | 16197 | 0.730 |
Why?
|
| Hypercalcemia | 1 | 2019 | 12 | 0.690 |
Why?
|
| Carcinoma, Ductal | 1 | 2019 | 3 | 0.690 |
Why?
|
| Breast Neoplasms, Male | 1 | 2019 | 9 | 0.690 |
Why?
|
| Referral and Consultation | 2 | 2021 | 86 | 0.680 |
Why?
|
| Tamoxifen | 1 | 2019 | 30 | 0.680 |
Why?
|
| Stromal Cells | 1 | 2018 | 35 | 0.650 |
Why?
|
| Hemangiosarcoma | 1 | 2017 | 3 | 0.640 |
Why?
|
| Disease Management | 2 | 2019 | 114 | 0.640 |
Why?
|
| Humans | 20 | 2023 | 29337 | 0.610 |
Why?
|
| Patient Compliance | 1 | 2018 | 164 | 0.600 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 132 | 0.600 |
Why?
|
| Inflammatory Breast Neoplasms | 1 | 2016 | 3 | 0.590 |
Why?
|
| Mastectomy, Segmental | 1 | 2016 | 13 | 0.580 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2016 | 36 | 0.570 |
Why?
|
| Body Mass Index | 1 | 2019 | 428 | 0.570 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2016 | 51 | 0.570 |
Why?
|
| Obesity | 1 | 2019 | 291 | 0.550 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 333 | 0.550 |
Why?
|
| Surgical Wound Infection | 1 | 2016 | 97 | 0.530 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 13 | 0.520 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2015 | 24 | 0.520 |
Why?
|
| Aged | 7 | 2023 | 9448 | 0.480 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 219 | 0.480 |
Why?
|
| Neoplasm Staging | 3 | 2022 | 340 | 0.470 |
Why?
|
| Skin Neoplasms | 2 | 2016 | 65 | 0.440 |
Why?
|
| Decision Making | 1 | 2015 | 220 | 0.440 |
Why?
|
| Aged, 80 and over | 5 | 2022 | 4851 | 0.430 |
Why?
|
| Oocytes | 2 | 2009 | 16 | 0.410 |
Why?
|
| Cryopreservation | 2 | 2009 | 24 | 0.400 |
Why?
|
| Postoperative Complications | 1 | 2016 | 957 | 0.360 |
Why?
|
| Case-Control Studies | 2 | 2023 | 638 | 0.340 |
Why?
|
| Sarcoma, Alveolar Soft Part | 1 | 2008 | 1 | 0.330 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 1830 | 0.320 |
Why?
|
| Infertility, Female | 1 | 2007 | 19 | 0.320 |
Why?
|
| Quality of Life | 2 | 2022 | 662 | 0.290 |
Why?
|
| Adult | 7 | 2022 | 8601 | 0.280 |
Why?
|
| Prognosis | 2 | 2019 | 840 | 0.240 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2023 | 18 | 0.230 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 79 | 0.220 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2019 | 14 | 0.220 |
Why?
|
| Time Factors | 4 | 2019 | 1616 | 0.210 |
Why?
|
| Mutation | 1 | 2023 | 383 | 0.200 |
Why?
|
| Length of Stay | 1 | 2023 | 317 | 0.200 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2018 | 75 | 0.190 |
Why?
|
| Acellular Dermis | 1 | 2019 | 6 | 0.180 |
Why?
|
| Breast Implantation | 1 | 2019 | 2 | 0.180 |
Why?
|
| Breast Implants | 1 | 2019 | 3 | 0.180 |
Why?
|
| Middle Aged | 4 | 2023 | 9823 | 0.180 |
Why?
|
| Mammography | 1 | 2019 | 34 | 0.170 |
Why?
|
| Treatment Outcome | 2 | 2019 | 3478 | 0.170 |
Why?
|
| Phyllodes Tumor | 1 | 2017 | 1 | 0.160 |
Why?
|
| Rare Diseases | 1 | 2017 | 11 | 0.160 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 364 | 0.160 |
Why?
|
| Fatal Outcome | 1 | 2016 | 59 | 0.150 |
Why?
|
| Needles | 1 | 2016 | 18 | 0.140 |
Why?
|
| Age Factors | 1 | 2018 | 843 | 0.140 |
Why?
|
| Biopsy | 1 | 2015 | 234 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 402 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 1221 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 770 | 0.090 |
Why?
|
| Young Adult | 1 | 2016 | 1932 | 0.090 |
Why?
|
| Amenorrhea | 1 | 2009 | 2 | 0.090 |
Why?
|
| Embryo, Mammalian | 1 | 2009 | 31 | 0.090 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2007 | 17 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 218 | 0.080 |
Why?
|
| Ultrasonography | 1 | 2008 | 226 | 0.070 |
Why?
|
| Male | 1 | 2019 | 15621 | 0.050 |
Why?
|
| Adolescent | 1 | 2008 | 2279 | 0.050 |
Why?
|
| Esthetics | 1 | 2019 | 9 | 0.040 |
Why?
|
| Radiologists | 1 | 2019 | 6 | 0.040 |
Why?
|
| Margins of Excision | 1 | 2019 | 17 | 0.040 |
Why?
|
| Pectoralis Muscles | 1 | 2019 | 18 | 0.040 |
Why?
|
| Intraoperative Care | 1 | 2019 | 44 | 0.040 |
Why?
|
| Operative Time | 1 | 2019 | 80 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 144 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2019 | 127 | 0.040 |
Why?
|
| Wound Healing | 1 | 2019 | 168 | 0.040 |
Why?
|
| Surgeons | 1 | 2019 | 76 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2019 | 394 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 222 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2019 | 330 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2019 | 679 | 0.040 |
Why?
|
| Prosthesis Failure | 1 | 2019 | 556 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 1939 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2009 | 53 | 0.020 |
Why?
|